Arabic version: عائلة تسافر إلى الخارج لعلاج خلايا جذعية مثير للجدل
A Port Macquarie family has traveled to Thailand for unproven stem cell therapy in hopes of improving their son’s rare eye condition. Reid Mowle, diagnosed with septo-optic dysplasia with optic nerve hypoplasia, has shown signs of improvement following the treatment, according to his parents. Reid’s mother, Sarah Hardy, made the decision to seek treatment overseas after consulting with specialists and other families dealing with similar conditions.
According to ABC News, Reid’s condition affects a small number of Australians, with only 54 cases reported at the time of his diagnosis. Hardy expressed her relief at noticing changes in Reid’s behavior after the treatment, stating that he began to recognize family members and communicate his observations.
Despite the positive changes, experts caution against the use of unregulated stem cell therapies. Professor Megan Munsie, a leading researcher in stem cell technologies, emphasized that many treatments offered overseas have not been clinically proven or approved in Australia. She warned that patients should be wary of claims made by rogue clinics and highlighted the importance of validating the safety and efficacy of treatments.
Reid’s family faced significant costs, with the treatment and travel amounting to approximately $50,000. Despite concerns from some medical professionals regarding the treatment’s efficacy, Hardy remains hopeful that stem cell therapies will become more accessible in Australia in the future. She advocates for the development of approved treatments that could benefit many families dealing with similar health challenges.
As research progresses in the field of stem cell therapies, specialists like Professor Alex Hewitt believe that there is potential for advancements in treating eye conditions, including those similar to Reid’s. While there are currently no approved stem cell therapies for septo-optic dysplasia in Australia, the ongoing research in this area offers hope for future treatments.
